HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of peritoneal dialysis-induced hydrothorax in children.

Abstract
Continuous ambulatory peritoneal dialysis (CAPD) is a safe and effective treatment for children with end-stage renal failure. Approximately three per cent of patients develop a large hydrothorax as a result of a dialysate leak from the peritoneal cavity through an occult diaphragmatic eventration or attenuation of the pleuroperitoneal membrane. Previously, such patients often discontinued CAPD and were placed on hemodialysis even though the complications, expense, and limitation of activity with hemodialysis are undesirable in children. During the past 15 years, 6 of the 193 children (3%) undergoing CAPD at UCLA Medical Center developed a hydrothorax. Three patients were male and three were female. Four patients were treated surgically with diaphragmatic plication, one was treated by reducing the dialysate volume, and one was switched to hemodialysis in preparation for a renal transplant. Each of the four surgically-treated children was able to return to full-volume peritoneal dialysis and has not experienced recurrence of the hydrothorax. Therefore, diaphragmatic plication permits children to quickly resume full-volume CAPD and avoid hemodialysis.
AuthorsA L Kawaguchi, J C Dunn, E W Fonkalsrud
JournalThe American surgeon (Am Surg) Vol. 62 Issue 10 Pg. 820-4 (Oct 1996) ISSN: 0003-1348 [Print] United States
PMID8813163 (Publication Type: Case Reports, Journal Article)
Topics
  • Child, Preschool
  • Diaphragm (surgery)
  • Female
  • Humans
  • Hydrothorax (diagnosis, etiology, surgery)
  • Infant
  • Kidney Failure, Chronic (therapy)
  • Male
  • Peritoneal Dialysis, Continuous Ambulatory (adverse effects)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: